| Literature DB >> 28407484 |
Feng Zhu1, Jami Willette-Brown1, Na-Young Song1, Dakshayani Lomada2, Yongmei Song3, Liyan Xue4, Zane Gray1, Zitong Zhao3, Sean R Davis5, Zhonghe Sun6, Peilin Zhang7, Xiaolin Wu6, Qimin Zhan3, Ellen R Richie2, Yinling Hu8.
Abstract
Humans with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), a T cell-driven autoimmune disease caused by impaired central tolerance, are susceptible to chronic fungal infection and esophageal squamous cell carcinoma (ESCC). However, the relationship between autoreactive T cells and chronic fungal infection in ESCC development remains unclear. We find that kinase-dead Ikkα knockin mice develop APECED-like phenotypes, including impaired central tolerance, autoreactive T cells, chronic fungal infection, and ESCCs expressing specific human ESCC markers. Using this model, we investigated the link between ESCC and fungal infection. Autoreactive CD4 T cells permit fungal infection and incite tissue injury and inflammation. Antifungal treatment or autoreactive CD4 T cell depletion rescues, whereas oral fungal administration promotes, ESCC development. Inhibition of inflammation or epidermal growth factor receptor (EGFR) activity decreases fungal burden. Fungal infection is highly associated with ESCCs in non-autoimmune human patients. Therefore, autoreactive T cells and chronic fungal infection, fostered by inflammation and epithelial injury, promote ESCC development. Published by Elsevier Inc.Entities:
Keywords: EGFR; IKKalpha; autoimmune disease; autoreactive T cells; esophageal squamous cell carcinoma; fungal infection; inflammation; mucosal epithelium
Mesh:
Substances:
Year: 2017 PMID: 28407484 PMCID: PMC5868740 DOI: 10.1016/j.chom.2017.03.006
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023